Atossa Therapeutics
ATOS
#10745
Rank
NZ$36.45 M
Marketcap
NZ$3.65
Share price
2.55%
Change (1 day)
162.70%
Change (1 year)

Atossa Therapeutics (ATOS) - P/B ratio

P/B ratio as of November 2026 : 0.7439

According to Atossa Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Atossa Therapeutics - P/B ratio (from 2012 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-312.0719.87%
2024-12-311.7342.53%
2023-12-311.21113.56%
2022-12-310.5673-61.32%
2021-12-311.47-11.79%
2020-12-311.6652.59%
2019-12-311.0960.89%
2018-12-310.6773-43.85%
2017-12-311.21-30.06%
2016-12-311.72-38.25%
2015-12-312.79-24.48%
2014-12-313.70-9.01%
2013-12-314.06-58.25%
2012-12-319.74
2011-12-31N/A
2010-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
8.39 1,027.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
3.59 382.88%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
3.50 370.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
2.52 238.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
0.8431 13.33%๐Ÿ‡บ๐Ÿ‡ธ USA